Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gavin Cloherty

Showing results (31-40 of 127) with videos related to

Pageof 13
Sort By:
Scientific Reports|December 14, 2021
More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replicationKa-Cheung Luk, Jeffrey Gersch, Barbara J Harris, et al.
Antiviral Research|December 20, 2024
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cureLeeor Hershkovich, Scott J Cotler, Louis Shekhtman, et al.
The American Journal of Tropical Medicine and Hygiene|July 2, 2026
Arbovirus Circulation among Patients with Acute Encephalitis: West Nile Virus Infection among Humans in Bangladesh, 2022Syeda Tasnuva Maria, Mallick Masum Billah, Quazi Ahmed Zaki, et al.
Journal of Clinical Microbiology|October 4, 2013
Impact of the New Abbott mPLUS feature on clinical laboratory efficiencies of abbott RealTime assays for detection of HIV-1, Hepatitis C Virus, Hepatitis B Virus, Chlamydia trachomatis, and Neisseria gonorrhoeaeDanijela Lucic, Sara Jones, Russ Wiesneth, et al.
Vaccines|November 24, 2022
Correlation of Binding and Neutralizing Antibodies against SARS-CoV-2 Omicron Variant in Infection-Naïve and Convalescent BNT162b2 RecipientsJia Fu, Xiaoying Shen, Mark Anderson, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 23, 2024
Evaluation of a fully automated high-throughput serology assay for detection of Hepatitis D virus antibodiesXiaoxing Qiu, Abbas Hadji, Ana Olivo, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
A Targeted Geospatial Approach to COVID-19 Vaccine Delivery: Findings from the Johns Hopkins Hospital Emergency DepartmentSunil S Solomon, Yu-Hsiang Hsieh, Richard E Rothman, et al.
Vaccine|December 26, 2022
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individualsTimothy G Kuzel, Jia Fu, Mark Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue TherapyMark Anderson, Jeffery Gersch, Ka-Cheung Luk, et al.
The Journal of Infectious Diseases|October 31, 2024
Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue WithdrawalNorah A Terrault, Richard Sterling, Anna S Lok, et al.
Pageof 13

Showing results (31-40 of 127) with videos related to

Sort By:
Pageof 13
Scientific Reports|December 14, 2021
More DNA and RNA of HBV SP1 splice variants are detected in genotypes B and C at low viral replicationKa-Cheung Luk, Jeffrey Gersch, Barbara J Harris, et al.
Antiviral Research|December 20, 2024
HBV serum RNA kinetics during nucleic acid polymers based therapy predict functional cureLeeor Hershkovich, Scott J Cotler, Louis Shekhtman, et al.
The American Journal of Tropical Medicine and Hygiene|July 2, 2026
Arbovirus Circulation among Patients with Acute Encephalitis: West Nile Virus Infection among Humans in Bangladesh, 2022Syeda Tasnuva Maria, Mallick Masum Billah, Quazi Ahmed Zaki, et al.
Journal of Clinical Microbiology|October 4, 2013
Impact of the New Abbott mPLUS feature on clinical laboratory efficiencies of abbott RealTime assays for detection of HIV-1, Hepatitis C Virus, Hepatitis B Virus, Chlamydia trachomatis, and Neisseria gonorrhoeaeDanijela Lucic, Sara Jones, Russ Wiesneth, et al.
Vaccines|November 24, 2022
Correlation of Binding and Neutralizing Antibodies against SARS-CoV-2 Omicron Variant in Infection-Naïve and Convalescent BNT162b2 RecipientsJia Fu, Xiaoying Shen, Mark Anderson, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 23, 2024
Evaluation of a fully automated high-throughput serology assay for detection of Hepatitis D virus antibodiesXiaoxing Qiu, Abbas Hadji, Ana Olivo, et al.
Medrxiv : the Preprint Server for Health Sciences|May 20, 2021
A Targeted Geospatial Approach to COVID-19 Vaccine Delivery: Findings from the Johns Hopkins Hospital Emergency DepartmentSunil S Solomon, Yu-Hsiang Hsieh, Richard E Rothman, et al.
Vaccine|December 26, 2022
Effects of a booster dose of BNT162b2 on spike-binding antibodies to SARS-CoV-2 Omicron BA.2, BA.3, BA.4 and BA.5 subvariants in infection-naïve and previously-infected individualsTimothy G Kuzel, Jia Fu, Mark Anderson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Circulating Pregenomic Hepatitis B Virus RNA Is Primarily Full-length in Chronic Hepatitis B Patients Undergoing Nucleos(t)ide Analogue TherapyMark Anderson, Jeffery Gersch, Ka-Cheung Luk, et al.
The Journal of Infectious Diseases|October 31, 2024
Hepatitis B Virus RNA as a Biomarker for Safe Antiviral Discontinuation: A Prospective Study of Nucleos(t)ide Analogue WithdrawalNorah A Terrault, Richard Sterling, Anna S Lok, et al.
Pageof 13